Suppr超能文献

颈部吻合肌瓣植入在食管癌三切口根治术中的应用:系统评价与Meta分析方案

Application of neck anastomotic muscle flap embedded in 3-incision radical resection of oesophageal carcinoma: A protocol for systematic review and meta analysis.

作者信息

Tong Zhangwei, Yang Xiaojie, Luo Fei, Zhu Jiafu, Kang Mingqiang, Lin Jiangbo

机构信息

Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.

出版信息

Medicine (Baltimore). 2020 Oct 9;99(41):e22263. doi: 10.1097/MD.0000000000022263.

Abstract

BACKGROUND

Oesophageal cancer is one of the most common malignant tumors and has been identified as one of the leading causes of cancer death worldwide. Surgery is considered to be the optimal treatment for patients with resectable oesophageal cancer. Oesophagectomy for oesophageal cancer can significantly extend the survival period of patients and provide a potential opportunity for a cure. However, there is still controversy regarding application of neck anastomotic muscle flap embedded. This systematic review and meta-analysis will be performed to determine whether the application of neck anastomotic muscle flap embedded would benefit patients more.

METHODS

We will search PubMed, Web of Science, Embase, Cancerlit, the Cochrane Central Register of Controlled Trials, and Google Scholar databases for relevant clinical trials published in any language before October 1, 2020. Randomized controlled trials (RCTs), quasi-RCTs, propensity score-matched comparative studies, and prospective cohort studies of interest, published or unpublished, that meet the inclusion criteria will be included. Subgroup analysis of the type of operation, tumor pathological stage, and ethnicity will be performed. INPLASY registration number: INPLASY202080059.

RESULTS

The results of this study will be published in a peer-reviewed journal.

CONCLUSION

As far as we know, this study will be the first meta-analysis to compare the efficacy of the application of neck anastomotic muscle flap embedded in 3-incision radical resection of oesophageal carcinoma. Due to the nature of the disease and intervention methods, RCTs may be inadequate, and we will carefully consider inclusion in high-quality, non-RCTs, but this may result in high heterogeneity and affect the reliability of the results.

摘要

背景

食管癌是最常见的恶性肿瘤之一,已被确定为全球癌症死亡的主要原因之一。手术被认为是可切除食管癌患者的最佳治疗方法。食管癌切除手术可显著延长患者生存期,并提供治愈的潜在机会。然而,关于带蒂胸大肌肌皮瓣在颈部吻合术中的应用仍存在争议。本系统评价和荟萃分析将确定带蒂胸大肌肌皮瓣在颈部吻合术中的应用是否能使患者更多获益。

方法

我们将检索PubMed、Web of Science、Embase、Cancerlit、Cochrane对照试验中心注册库和谷歌学术数据库,以查找2020年10月1日前以任何语言发表的相关临床试验。符合纳入标准的已发表或未发表的随机对照试验(RCT)、半随机对照试验、倾向评分匹配的比较研究和前瞻性队列研究将被纳入。将对手术类型、肿瘤病理分期和种族进行亚组分析。INPLASY注册号:INPLASY202080059。

结果

本研究结果将发表在同行评审期刊上。

结论

据我们所知,本研究将是第一项比较带蒂胸大肌肌皮瓣在食管癌三切口根治术中应用效果的荟萃分析。由于疾病性质和干预方法的原因,RCT可能不足,我们将仔细考虑纳入高质量的非RCT,但这可能导致高度异质性并影响结果的可靠性。

相似文献

5
Postoperative adjuvant therapy for resectable esophageal cancer: A protocol of a systematic review and meta-analysis.
Medicine (Baltimore). 2019 May;98(20):e15485. doi: 10.1097/MD.0000000000015485.
7
Platinum versus immunotherapy for unresectable esophageal cancer: A protocol for systematic review and meta analysis.
Medicine (Baltimore). 2020 Dec 18;99(51):e23537. doi: 10.1097/MD.0000000000023537.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
3
Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis.
Onco Targets Ther. 2016 Oct 31;9:6751-6762. doi: 10.2147/OTT.S112105. eCollection 2016.
4
Comparison of outcomes between minimally invasive oesophagectomy and open oesophagectomy for oesophageal cancer.
ANZ J Surg. 2017 Mar;87(3):165-170. doi: 10.1111/ans.13334. Epub 2015 Oct 19.
6
Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions.
Res Synth Methods. 2012 Jun;3(2):161-76. doi: 10.1002/jrsm.57. Epub 2012 Jun 1.
7
Increased expression levels of S100A4 associated with hypoxia-induced invasion and metastasis in esophageal squamous cell cancer.
Tumour Biol. 2014 Dec;35(12):12535-43. doi: 10.1007/s13277-014-2573-x. Epub 2014 Sep 13.
8
Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma.
J Thorac Oncol. 2012 Sep;7(9):1457-61. doi: 10.1097/JTO.0b013e318260dfe8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验